Metalloenzymes and metal homeostasis

金属酶和金属稳态

基本信息

  • 批准号:
    10589084
  • 负责人:
  • 金额:
    $ 62.84万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-04-01 至 2026-03-31
  • 项目状态:
    未结题

项目摘要

Project Summary This research program centers on the bioinorganic chemistry of methanotrophic bacteria, microbes that convert methane, a potent greenhouse gas, to methanol in the first step of their metabolic pathway. As the primary methane sink in nature, methanotrophs are promising tools to mitigate the deleterious effects of global warming on human health, and may be deployed to generate fuels and chemicals from methane in an environmentally-friendly fashion. Moreover, some methanotrophs produce copper-binding natural products that are under investigation as therapeutics. The proposed projects take an integrated biochemical, biophysical, structural, and genetic approach to understanding these processes on the molecular level. The first project addresses the structure and function of particulate methane monooxygenase (pMMO), an integral membrane, copper-dependent enzyme that catalyzes the oxidation of methane to methanol. Despite the availability of pMMO crystal structures and a range of spectroscopic data, the location and atomic details of the copper active site remain unclear, and the sites of substrate, product, and reductant binding have not been elucidated, all prerequisites for elucidating the chemical mechanism. The experimental approach involves characterization of new pMMOs with highly divergent sequences, structural determination of pMMOs in a lipid environment that maintains enzymatic activity, and genetic manipulation of native methanotrophs. The results will lead to a comprehensive understanding of this critically important metalloenzyme and will further understanding of homologs such as ammonia monooxygenase (AMO), another contributor to climate change. The second project focuses on methanobactins (Mbns), ribosomally produced, post-translationally modified natural products secreted by methanotrophs to scavenge copper from the environment. The machinery to biosynthesize and transport Mbns is encoded in Mbn operons, which are also present in a wide range of non- methanotrophic bacteria, suggesting additional functions and unexplored diversity in structure. Mechanistic and structural studies of the core biosynthetic enzyme complex, the iron-containing MbnBC heterodimer, along with characterization of other biosynthetic proteins will be conducted. In addition, the involvement of other operon proteins in release of copper from Mbn will be investigated using both biochemical and in vivo strategies. Taken together, the results will provide new insights into natural products biosynthesis and will impact the use of these molecules as therapeutics for Wilson disease and other disorders of copper metabolism.
项目摘要 这个研究项目的中心是甲烷氧化细菌的生物无机化学, 在它们代谢途径的第一步,将甲烷(一种强有力的温室气体)转化为甲醇。为 甲烷氧化菌是自然界中主要的甲烷汇,是减轻全球甲烷污染的有害影响的有前途的工具。 气候变暖对人类健康的影响,并可能被部署在一个由甲烷产生燃料和化学品的地方。 环保时尚。此外,一些甲烷氧化菌产生结合铜的天然产物, 正在研究中拟议的项目采取综合的生物化学,生物物理, 结构和遗传的方法来理解这些过程在分子水平上。 第一个项目涉及颗粒甲烷单加氧酶(pMMO)的结构和功能, 一种完整的膜,铜依赖酶,催化甲烷氧化为甲醇。尽管 pMMO晶体结构和一系列光谱数据的可用性, 铜的活性部位仍不清楚,底物、产物和还原剂结合的部位也不清楚。 阐明,阐明化学机制的所有先决条件。实验方法包括 具有高度不同序列的新pMMO的表征,脂质中pMMO的结构测定 保持酶活性的环境,以及天然甲烷氧化菌的遗传操作。结果 将导致对这种至关重要的金属酶的全面了解,并将进一步 了解同系物,如氨单加氧酶(AMO),气候变化的另一个贡献者。 第二个项目的重点是甲烷氧化菌素(Mbns),核糖体产生的, 由甲烷氧化菌分泌的改性天然产物,以从环境中除去铜。机械 生物合成和运输Mbns的基因编码在Mbn操纵子中,这些操纵子也存在于广泛的非- 甲烷氧化细菌,表明额外的功能和未开发的结构多样性。机械和 核心生物合成酶复合物的结构研究,含铁的MbnBC异二聚体,沿着 将进行其他生物合成蛋白质的表征。此外,其他操纵子的参与 将使用生物化学和体内策略来研究蛋白质在从MBN释放铜中的作用。采取 总之,这些结果将为天然产物的生物合成提供新的见解,并将影响这些天然产物的使用。 分子作为威尔逊病和其它铜代谢紊乱的治疗剂。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

AMY C. ROSENZWEIG其他文献

AMY C. ROSENZWEIG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('AMY C. ROSENZWEIG', 18)}}的其他基金

Admin supp: Metalloenzymes and metal homeostasis
管理支持:金属酶和金属稳态
  • 批准号:
    10798723
  • 财政年份:
    2016
  • 资助金额:
    $ 62.84万
  • 项目类别:
Metalloenzymes and metal homeostasis
金属酶和金属稳态
  • 批准号:
    9069232
  • 财政年份:
    2016
  • 资助金额:
    $ 62.84万
  • 项目类别:
Metalloenzymes and metal homeostasis
金属酶和金属稳态
  • 批准号:
    10376838
  • 财政年份:
    2016
  • 资助金额:
    $ 62.84万
  • 项目类别:
Metalloenzymes and metal homeostasis
金属酶和金属稳态
  • 批准号:
    10388934
  • 财政年份:
    2016
  • 资助金额:
    $ 62.84万
  • 项目类别:
Metalloenzymes and metal homeostasis
金属酶和金属稳态
  • 批准号:
    9894812
  • 财政年份:
    2016
  • 资助金额:
    $ 62.84万
  • 项目类别:
X-RAY CRYSTALLOGRAPHIC STUDIES OF PARTICULATE METHANE MONOOXYGENASE
颗粒甲烷单加氧酶的 X 射线晶体学研究
  • 批准号:
    7954306
  • 财政年份:
    2009
  • 资助金额:
    $ 62.84万
  • 项目类别:
Particulate Methane Monooxygenase
颗粒甲烷单加氧酶
  • 批准号:
    7942225
  • 财政年份:
    2009
  • 资助金额:
    $ 62.84万
  • 项目类别:
X-RAY CRYSTALLOGRAPHIC STUDIES OF PARTICULATE METHANE MONOOXYGENASE
颗粒甲烷单加氧酶的 X 射线晶体学研究
  • 批准号:
    7721958
  • 财政年份:
    2008
  • 资助金额:
    $ 62.84万
  • 项目类别:
X-RAY CRYSTALLOGRAPHIC STUDIES OF PARTICULATE METHANE MONOOXYGENASE
颗粒甲烷单加氧酶的 X 射线晶体学研究
  • 批准号:
    7598213
  • 财政年份:
    2007
  • 资助金额:
    $ 62.84万
  • 项目类别:
X-RAY CRYSTALLOGRAPHIC STUDIES OF METAL TRAFFICKING PROTEINS AND METALLOENZYMES
金属运输蛋白和金属酶的 X 射线晶体学研究
  • 批准号:
    7597912
  • 财政年份:
    2007
  • 资助金额:
    $ 62.84万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 62.84万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 62.84万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.84万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.84万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 62.84万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.84万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 62.84万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 62.84万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 62.84万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.84万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了